ALTHOUGH there are many biological studies dealing with zinc, little quantiative data have appeared regarding the concentration and turnover of this metal, especially for man. Interest in zinc metabolism has been stimulated-by the accumulating evidence which indicates that this metal is a constituent of several enzymes (Fischer, Tikkala and Mawson, 1955; Vallee, 1955) and is associated, also, with some pathological states (Daniel et al., 1956; Prout, Sierp and Whitmore, 1959; Herring et al., 1961; Fredricks, Tanaka and Valentine, 1960) . Our concern with the element stems from reports of the high concentration of zinc found in the prostate gland both in animals (Gunn et al., 1955) and man (Mawson and Fischer, 1 952).
specimen was assayed subsequently for 65Zn concentration, using the technique outlined below. The variaton of radiozinc localization within the prostate itself was investigated in 15 of these patients having benign hypertrophy. Multiple samples were taken from the different lobes (left, right, medial, anterior and posterior) of the gland for determination of 65Zn.
Digestion of organs.--Duplicate weighed samples of each specimen were covered and digested with 20 per cent NaOH in a chemical hood employing moderate heat for several hours. Throughout this period, the level of liquid was maintained by the addition of distilled water. To determine 65Zn concentration (per cent dose/g.), aliquots were taken from the resulting suspension for assav.
Recovery experiments were performed on freshly killed mouse organs to check the reliability of this digestion technique. Known activities of 65Zn (6-3 /uc contained in 1 ml.) were added to duplicate samples of each of the following animal organs: brain, lung, spleen, heart, liver, pancreas, kidney, adrenal, muscle and skin. As indicated in Table I , the results justified employing this method for the processing of the various human samples. 99.5 100-5 i 16* * Standard deviation.
Assay Of 65Zn.-Counting of organ suspensions was performed with a welltype scintillation counter, having a 111 inch diameter Nal-thallium activated crystal. This detector has a sensitivity of 2-92 x 105 cpm/,ac for 65Zn, established by calibration against National Bureau of Standards reference solutions. Corrections for physical decay of 65Zn (half-life 244.4 days) were made either from long term decay curves or from concurrent measurements of aliquots of dose solutions. Adequate counts were collected to assure an accuracy of better than 5 per cent.
IN vivo counting of prostate.-The localization of 65Zn by the intact prostate was attempted by using shielded rectal detectors possessing high gamma sensitivity. An Antol type 302 Geiger counter was inserted into a 4 mm. thick lead housing, whose external diameter was 17-5 mm. With a 1 cm. port at the distal end, this counting arrangement had a sensitivity of 100 cpm/,uc of 65Zn in contact with a source whose volume was 1 ml. More recently, a Nuclear-Chicago DS-8 scintillation probe was used similarly; its sensitivity with a 6 mm. diameter needle probe was 6700 cpm/,ac in contact.
Radioautography
(a) Prostatic sections. To study the localization of the administered radioisotope, radioautographs were prepared from 5-10 micron sections of prostate specimens obtained either at surgery or at autopsy. The organ samples were fixed overnight in absolute methyl alcohol to minimize loss of 65Zn and then cleared in xylene. Unstained sections were coated with Kodak Ltd. AR-10 stripping film (Pelc, 1956) , exposed for periods ranging between 14 and 250 days at 4°C. in the presence of a desiccant, after which they were developed for 8 minutes in D-19 developer at 18°C. Following fixing and washing, the radioautographs were stained either with hematoxylin and eosin or with methyl green-pyronin. To check for artifacts, control radioautographs were prepared from non-radioactive prostatic sections.
(b) Bone marrow smears. About a week after the infusion of 65Zn tracer doses, bone marrow aspirates from ten patients having no known hematological disorders were smeared in the darkroom on Kodak NTB plates and fixed with absolute methyl alcohol (Boyd, 1955) . Following exposure for over 200 days and photographic processing, the plates were stained with Giemsa.
RESULTS

Distribution of 65Zn in various organs and tissues
Widely diff-erent concentrations of radiozinc were found in the organs obtained at autopsy (Table II) . The highest levels are those of the liver, reaching about 0 050 per cent dose/g. (wet weight) within a few days following administration of the tagged metal. These values for the concentration in the liver are about 2-8 times greater than those in the pancreas, the next most active organ, and as much as 10-30 times the levels in muscle, the tissue with the lowest concentration in our study. Turnover of 65Zn in the liver is apparently slow; as late as 81 days following infusion of the radioisotope, the concentration is still about 0-013 per cent dose/g. The radioisotope is handled more rapidly by the pancreas, so that the maximum concentration, about 0X023 per cent dose/g., is attained by the second day. Within a week, the 65Zn level of the pancreas is reduced by two-thirds, and by 81 days, hardly a tenth remains. The maximum 65Zn concentration in the spleen, about half that of the pancreas, occurred on the third day. The small amounts of radiozinc in the seminal vesicles, bladder and muscle do not appear to change significantly with time.
The radioautographs prepared from the bone marrow smears ( Fig. 1-6 ) indicate that the greatest amounts of 65Zn are taken up by all early forms of the hematopoietic series. Megakaryocytes are aiso very heavily labeled. Mature leucocytes take up lesser amounts of the radioisotope. Since virtually no grains appear over the erythrocytes, they must contain comparatively little 65Zn. No difference between the accumulation of radiozinc in nucleus and cytoplasm of the leucocyte can be discerned. 65Zn concentration by the prostate Among the organs assayed at autopsy, the prostate holds intermediate rank with respect to its ability to concentrate 65Zn (Table II) . For the eight males so studied, the mean 65Zn concentration is 0 00495 per cent dose/g. (wet weight) with values ranging between 0-00150 and 0 0117. Compared to the other organs, the ability of the gland to take up administered 65Zn is very variable; it is also not related to time.
This finding of widely scattered radiozine values independent of the interval following the infusion of the tracer is reinforced by the measurements made on the surgical specimens of the prostate obtained from 36 patients (Table III) . . , . . , _ 6 , . . . (Table IV) . The fluctuation in 65Zn values is very great, as much as a seven-fold range being observed for one case. For 12 of these patients, the coefficient of variation for the concentration within the gland was greater than 20 per cent. Moreover, levels of the radioisotope cannot be related consistently to specific anatomical regions of the gland. Right (1) Left (1) Median (1) Anterior ( Not identified (6) Right (4) Left (8) B. B-.
Right (1) Left (1) Median (
. 11 .
Right (1) Left (1) Anterior (1) Posterior (1) No significant difference in the concentration of 65Zn can be associated with the condition of the prostate. The results for the entire 44 patients studied are assembled in Table III , grouped according to the status of the gland. For the four patients with normal prostates, a mean 65Zn concentration of 5*85 ± 2.66* X 10-3 per cent dose/g. was found; the corresponding average for the five patients having prostatic malignancy is 7-17 ± 3-63 x 10 -3 per cent dose/g. These levels are lower, but not significantly, than those for the 35 patients having benign hyperplasia of the gland (average 10-78 ± 6-41 x 10 -3 per cent dose/g.).
Since a valid statistical difference is not demonstrable, these 44 patients are considered a homogenous population having a mean 65Zn concentration of 9-92 + 6-15 x 10-3 per cent dose/g. These marked differences in 65Zn concentrations within the prostate are encountered also on the histological level as demonstrated by radioautography (Fig. 7-18 ). While the follicles have a great affinity for the radioisotope, they exhibit vast differences in this respect. Our preparations indicate that the follicular deposition of 65Zn is spotty. The glandular units frequently involved in localizing the radioisotope are the smaller ones. Although follicular uptake varies, both apocrine-and holocrine-like units actively accumulate the radiometal. The sequestered cellular material within the holocrine type acini is strongly labeled. Grains are frequently located over the lumens and ducts, although never as many as over the border epithelium of the acini. For active follicles, 65Zn is restricted to the border epithelial cells, principally the cytoplasm. No significant amounts of activity are present in adjacent muscle and connective tissues.
The attempts to perform in vivo surveys proved unsatisfactory. While the detectors indicated higher than background levels when inserted into the rectum, the counting pattern did not correspond to the anatomical location of the gland.
DISCUSSION
Little is available in the literature regarding the fate of this radioisotope, particularly its behaviour in man. Adequate studies of the fraction of the tagged zinc concentrated in various organs by an appreciable number of human subjects are yet to be reported. It is consequently difficult to relate our findings with those published by others.
65Zn as a tracer.-A question meriting evaluation is whether the 65Zn doses employed by us, as well as those given by others in conducting human and animal studies, are physiological. The relationship of the specific activity of administered 65Zn to organ localization requires clarification. This consideration may have a strong bearing on the discrepancies found between the distribution of radiozinc and that of stable zinc. For laboratory animals, whose body weights and total zinc contents are much smaller than those of man, it may well be that the amount of carrier given has influenced the observed behaviour of 65Zn. Since figures for specific activity are frequently omitted, the importance of carrier cannot be assessed for many reports (Tables V and VI) .
The 65Zn furnished us has a specific activity ranging between 83-6 and 93-5 nic/g., so that about one-half to one milligram of zinc was contained in each dose. (Table IV) . This approach has the overriding merit, however, of providing a basis for a crude analysis of 65Zn kinetics.
Considering the errors made in assuming homogeneous organ distribution of 65Zn and in employing average organ weights, the agreement is surprisingly good between both forms of zinc for most organs, including the prostate and pancreas (Table VI) . Organ uptake of 65Zn, unlike concentration measurements, could be thus expected to reflect the handling of stable zinc. The liver, however, is a notable exception, since it takes up a much higher fraction of the 65Zn dose than its relative content of the stable metal. MIeselhan et al. (Daniel et al., 1956; Prout et al., 1959; Ross et al., 1958 ) and the dog (Sheline et al., 1943; Meschan et al., 1959) , but are higher than the corresponding values for the mouse (Sheline et al., 1943) and rat (Gilbert and Tavlor, 1956; Ballou, 1959) . The variation of 65Zn uptake in the liver with time is noteworthy (Fig. 19) . The maximum level occurs about the seventh day, declining quite slowly thereafter. As late as 174 days after injection, 3 8 per cent of the dose is still present in the liver. In comparison to the mouse and dog, the levels and turnover of 65Zn in the liver of man are quite different (Fig. 19) . The peaks for the animals are reached early, before the end of the first day. Furthermore, the disappearance of 65Zn in the mouse and dog is so rapid, that by the end of the first week, only 3*3 per cent of the dose remains in the liver of the mouse and 3-5 per cent in the same organ of the dog. Gilbert and Taylor (1956) have also observed an early fall of 65Zn uptake in the liver of the rat, so that only 1 6 per cent of the dose is retained 35 days after administration of the dose.
As the determinations of permissible levels of 65Zn in man have been hitherto based on animal studies (National Bureau of Standards, 1959) , the values and the turnover being reported here may have a bearing on these calculations. Bone is being taken as the critical organ, since the studies in animals conducted by Sheline et al., (1943) indicate a longer biological half-life of administered 65Zn in bone than either in liver or in pancreas. As noted earlier, while both of the latter organs in man accumulate high levels of 65Zn rapidly, the turnover in the pancreas is faster. Our data indicate that the biological half-life of 65Zn in the liver of man is about 75 days, a gross estimate because of the few points available- (Fig. 19) . Although considerable error is associated with this value, it is certainly longer than the 23 days found for bone of the dog (Sheline et al., 1943) . Further studies along these lines are needed to establish more precisely the turnover in human bone and liver in order to reduce the uncertainty in dosage computations. -erythrocytes demonstrated by our radioautographs confirm observations based -on studies with stable zinc and recently with 65Zn. Thus, it is believed that the leucocyte probably contains more zinc than any other cell of the body (Vikbladh, 1951) ; the white cells have as much as 3 per cent of whole blood zinc (Vallee -and Gibson, 1948) . The zinc ratio of leucocyte to erythrocyte is about 20 (Ross et al., 1958) or 15 (Dennes, Tupper and Wormall, 1961) . This latter group has found also that two hours after incubation of whole blood with a 65Zn-glycine solution, the leucocyte to erythrocyte ratio for the radioisotope is about 57. Of mnore direct interest are their experiments in rabbits, indicating that 24 hours Sheline et al. (1943) for dog and mouse. Each point plotted for the mouse refers to the average of 3-7 animals.
For man and for dog, each point represents the uptake of a single subject. In.set.-The long-term variation of 6&Zn uptake by the human liver is graphed semi-logarithmically.
after administration of 65Zn, a similarly high ratio (about 30) is found in the bone marrow.
65Zn in the prostate.-A dominant feature of the findings presented here is the low and variable total uptake of 65Zn by the human prostate (Table IV) . As .already remarked, hardly one per cent of the administered radioisotope is taken up by the gland, an approximate value in view of the non-uniform 65Zn con-*centration within the organ. In any event, 65Zn in the prostate of man does not .approach the concentration and uptake of 131J by the thyroid, as had been claimed (Gunn et al., 1955) .
The fluctuation of prostatic 65Zn concentration among our patients is considerably greater than that reported by others. While an eight-fold variation was found in the necropsy specimens from eight male patients, an even greater ratio of about 15 was encountered in the surgical specimens from 36 patients 660 E. SIEGEL, F. A. GRAIG, M. M. CRYSTAL AND ELSIE P. SIEGEIL (Table III) . A factor of only 12 is indicated in the series of 15 patients studied with 65Zn by Daniel et al. (1956) and an even smaller ratio, about seven, is found for the 21 cases investigated by Prout et al. (1959) . It should be noted that stable zinc levels are likewise variable, Hoare, Delory and Penner (1956) having observed an 11-fold range in 19 normal prostates.
Our observation that the variation of 65Zn concentration within the gland is unrelated to anatomy (Table IV) does not agree with some stable zinc determinations in man or with radiozinc studies in the rat. Thus, Kerr, Kerestechi and Mayoh (1960) concluded that levels of stable zinc increase toward the apex of the human prostate. They found great variations in concentration of the metal, as much as 18-fold, for different portions of the gland. On the other hand, Mager, McNary and Lionetti (1953) , using histochemical methods, could not detect differences in zinc content between the anterior and posterior lobes of the human, canine and simian prostates. In the rat, Gunn et al. (1955) found that the dorsolateral prostate concentrates about 20 times as much 65Zn as the ventral portion. More recently, they have shown that the lateral tip of the dorsolateral gland, composed exclusively of apocrine type acini, is concerned with 65Zn uptake, but is low in fructose ; the dorsal tip, however, comprised of holocrinelike units, is devoid of 65Zn, but is high in fructose (Gunn and Gould, 1957) .
The low uptake of 65Zn by the prostate together with the relatively high levels of the radioisotope in the liver, bladder and blood (Graig and Siegel, 1960) account, we believe, for our failure to perform satisfactory measurements of uptake by the prostate using rectal detectors. This comparatively poor localization dims the hope of applying such in vivo counting techniques for diagnosis or for determining indices of function, unless much higher ratios are encounltered for pathological states of the prostate. Our findings are in accord with the meager evidence available (Mawson and Fischer, 1952 ; Daniel et al., 1956; Prout et al., 1959; Kerr et al., 1960) which suggests that the reverse is more probable.
Neither 65Zn concentration nor total uptake by the prostate was founld to vary with the period elapsing between administration of the radioisotope and removal of the specimen, a disturbing finding. This is obviously not a firm conclusion, since it is based on single observations for each patient. The marked variation in 65Zn concentration, the error made in estimating the weight of the gland, and the unknown role of carrier already alluded to, are additional factors. obscuring any temporal relationship, if indeed one exists. 65Zn concentration and prostatic status. We were unable to demonstrate a correlation between the concentration of the tracer and the state of the prostate. Such a relationship might be expected in view of the stable zinc determinations indicating depressed concentrations in the presence of malignancy (Mawson and Fischer, 1952; Hoare et al., 1956; Kerr et al., 1960) . While the mean 65Zn1 concentration of the five malignant prostates in our series is higher than the average for the four normal glands and lower than that of the 35 benign hyperplastic prostates, the differences are not statistically significant due to the very great dispersion among the individual values. Among 15 patients investigated, Daniel et al. (1956) found that the 65Zn concentrations in two of their three malignant prostates were not appreciably lower. Indeed, the highest 65Zn level in any tissue studied by them occurred in the untreated prostatic carcinoma of their third patient. Prout et al. (1959) -82-13-7 ing miaximnum values in the seventies, to decline thereafter? The variation in the concentration data precludes a definitive response, but further inquiry seems warranted. It is noteworthy that this trend of increasing concentration with age is present also in the data of Prout et al. (1959) for their nine patients with benign hyperplasia. Perhaps this rise in 65Zn with age is related to the corresponding increase in weight of the prostate and its decrease sometime during the eighth decade (Simnmonds, 1918) . In this connection, mention should be made of the finding of Fischer et al. (1955) that the stable zinc concentration of the dorsolateral prostate of the rat increases with age, reaching a maximum at about 160 (lays. Gunn et al. (1955) also found that the prostates of rats six months and older picked up the largest amounts of 65Zn. Cellular and intracellular 65Zn in the prostate. The wide fluctuation in 65Zn content in the prostate gland, determined grossly by sample counting, is also found on a histological level by radioautography, which demonstrates that the follicles differ in their affinity for 65Zn. Histochemical confirmation is provided by;the studies performed with dithizone staining of the prostates of developing rats (Fischer et al., 1955) . As the rats become able to breed (about 50 days), a few areas within isolated acini become stainable. Several days thereafter, scattered acini are seen in which all the cells react positively. Spotty activity of follicles has been encountered in the study of other glands, an outstanding example being the thyroid gland with respect to its variable localization of 131I.
Some of the other findings from our radioautographs are also in good agreement with the literature. The localization of 65Zn by the border epithelium is in accord with the radioautograph published by Daniel et al. (1956) for human prostate and with those presented by Wetterdal (1958) and Millar, Vincenlt and Mawson (1961) for the dorsolateral prostate of the rat. Using the dithizone stain, Mager et al. (1953) studied the prostates of the dog, man, monkey and rabbit, reporting that the apical portions of the secretory cells were most intensely stained. They found that the associated connective and muscle tissues did not contain zinc. Employing a dithizone complex-forming solution to enhance specificity for zinc, this group showed, also, that the nuclei were non-staining. Gunn and Gould (1956) published a photomicrograph which demonstrated positive staining of the acini at the luminal border in the lateral prostate of the rat. Rixon and Whitfield (1959) confirmed this high concentration of zinc in lateral portions of the dorsolateral prostate of the rat, finding three regions witl positive staining: apical cytoplasm, nucleoli and sub-epithelial stroma.
In spite of the evidence just cited and confirmed by our radioautographs. the observation that the nuclei of the apical epithelium contain little or no 65Zn is unexpected, in view of the distribution of stable zinc in animal tumours and livers.
Heath (1949) and Heath and Liquier-Milward (1950) have reported that zinc is. associated with nucleoprotein from tumour tissues. Zinc has been found also in the nuclear fractions of nornmal rat livers (Thiers and Vallee, 1957) and of mousemammary tumours and livers (Bartholomew, Tupper and Wormall, 1959) . It should be remarked, however, that Rosenfeld and Tobias (1951) were unable to detect nucleoprotein-bound zinc in their studies.
The radioautographs inldicate that both holocrine and apocrine types of follicles can actively pick up 65Zn. As already noted, Gunn and Gould (1957) have shown that the lateral tips of the dorsolateral prostate, which are concerned with the localization of the radioisotope and devoid of fructose, are comprised exclusively of apocrine type acini. Conversely, the dorsal tips, which have a higher fructose content and reduced 65Zn levels, have only holocrine units. The situation in man is, apparently, unlike that which prevails in the rat.
SUMMARY
The distribution of 65Zn was studied in the organs of 14 patients at autopsy, occurring between 1 and 174 days following administration of 100 ,uc. The greatest concentration of the radioisotope is reached within a few days in the liver (about 0 050 per cent dose/g. wet weight), which localizes about 2-8 times more than the pancreas and as much as 10-30 times more than muscle. 65Zn leaves the liver slowly, 0-013 per cent dose/g. still being present 81 days after infusion. A more rapid turnover of the administered radioisotope occurs in the pancreas.
In this organ, the maximum concentration (about 0-023 per cent dose/g.) is attained by the second day; within a week, the level of the tagged metal has fallen by two-thirds, and bv 81 days, hardly a tenth remains. The maximum concentration of 65Zn in the spleen (0-0 13 per cent dose/g.) is about half that of the pancreas. For the spleen, as well as for those organs having even lower levels of the radioisotope (seminal vesicles, lung, bladder and muscle), no temporal relationship could be discerned.
The prostatic localization of 65Zn was studied by assaying autopsy specimen from 8 of these patients and surgical specimens from 36 others undergoing surgery.
For the entire series of 44 patients having normal, hyperplastic, or malignant prostates, the mean 65Zn concentration is 0-00992 ± 0-00615 per cent dose/g., ranging between 0-0315 and 0-00150; these 65Zn values are second only to those of the liver. No correlation could be demonstrated between the concentration of the radiometal and the condition of the prostate. By assaying samples of different lobes from the hyperplastic glands of 15 patients, marked variation in 65Zn concentrations is encountered within the organ unrelated to the anatomical subdivisions. Radioautographs of prostatic sections reveal that the deposition of the radioisotope, which is largely confined to the border epithelial cells, is not uniform. The smaller follicles accumulate the radioisotope predominantly, with both apocrine and holocrine type acini participating. Lesser amounts of the tagged metal are found in the lumens and ducts. f5Zn is concentrated principally by the cytoplasm of these border epithelial cells, insignificant amounts being taken up by the nuclei and by the associated connective and muscle tissues.
Radioautographs, prepared from bone marrow aspirates obtained about one week after 65Zn infusion, show that megakaryocytes and all early forms of the hematopoietic series are very heavily labeled. Mature leucocytes take up some 65Zn, but comparatively little of the nuclide is present in the erythrocytes.
The distribution pattern of the radioisotope is discussed in relation to stable zinc determinations in man. Our 65Zn data are compared also to those reported for experimental animals. Assuming uniform concentration throughout the organ, estimates are made of total organ uptake of 65Zn. The maximum accumulation of the administered tracer occurs in skeletal muscle and in liver, while pancreas and prostate have by far the lowest uptake. The effect of some factors on prostatic levels of 65Zn is considered. The intracellular deposition of 65Zn by the prostate of man is compared to the histochemical studies of stable zinc in man and experimental animals.
